Literature DB >> 33449933

Association between self-reported caffeine intake during pregnancy and social responsiveness scores in childhood: The EARLI and HOME studies.

Marisa A Patti1, Nan Li1, Melissa Eliot1, Craig Newschaffer2,3, Kimberly Yolton4,5, Jane Khoury4,5, Aimin Chen5, Bruce P Lanphear6, Kristen Lyall2, Irva Hertz-Picciotto7, Margaret Daniele Fallin8, Lisa A Croen9, Joseph M Braun1.   

Abstract

Maternal nutrition during gestation has been investigated for its role in child neurodevelopment. However, little is known about the potential impact of gestational caffeine exposure on child autistic behaviors. Here, we assess the relation between maternal caffeine intake during pregnancy and children's behavioral traits related to Autism Spectrum Disorder (ASD). We harmonized data from two pregnancy cohorts, Early Autism Risk Longitudinal Investigation (EARLI) (n = 120), an enriched-risk cohort of mothers who previously had a child with ASD, from Pennsylvania, Maryland, and Northern California (2009-2012), and the Health Outcomes and Measures of the Environment (HOME) Study (n = 269), a general population cohort from Cincinnati, Ohio (2003-2006). Mothers self-reported caffeine intake twice during pregnancy. Caregivers reported child behavioral traits related to ASD using the Social Responsiveness Scale (SRS) when children were aged 3-8 years. Higher scores indicate more ASD-related behaviors. We estimated covariate-adjusted differences in continuous SRS T-scores per interquartile range increase in caffeine intake. Self-reported caffeine intake during pregnancy was positively associated with SRS T-scores among children in EARLI (β: 2.0; 95% CI -0.1, 4.0), but to a lesser extent in HOME (β: 0.6; 95% CI -0.5, 1.6). In HOME, pre-pregnancy body mass index (BMI) modified the association between caffeine intake and SRS T-scores, where more positive associations were observed among women with higher BMIs. Our findings suggest gestational caffeine intake may represent a marker of vulnerability to childhood ASD-related behaviors. Additional studies are warranted to extend these findings.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33449933      PMCID: PMC7810310          DOI: 10.1371/journal.pone.0245079

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.240


  72 in total

1.  A Review on GABA/Glutamate Pathway for Therapeutic Intervention of ASD and ADHD

Authors:  Priyanka Purkayastha; Aruna Malapati; Perumal Yogeeswari; Dharmarajan Sriram
Journal:  Curr Med Chem       Date:  2015-05-04       Impact factor: 4.530

2.  Intrauterine exposure to caffeine and inattention/overactivity in children.

Authors:  M Bekkhus; T Skjøthaug; R Nordhagen; A I H Borge
Journal:  Acta Paediatr       Date:  2010-03-05       Impact factor: 2.299

3.  Concurrent medical conditions and health care use and needs among children with learning and behavioral developmental disabilities, National Health Interview Survey, 2006-2010.

Authors:  Laura A Schieve; Vanessa Gonzalez; Sheree L Boulet; Susanna N Visser; Catherine E Rice; Kim Van Naarden Braun; Coleen A Boyle
Journal:  Res Dev Disabil       Date:  2011-11-24

Review 4.  Caffeine: an evidence-based success story in VLBW pharmacotherapy.

Authors:  Nicole R Dobson; Carl E Hunt
Journal:  Pediatr Res       Date:  2018-07-09       Impact factor: 3.756

5.  Prevalence and Characteristics of Autism Spectrum Disorder Among 4-Year-Old Children in the Autism and Developmental Disabilities Monitoring Network.

Authors:  Deborah L Christensen; Deborah A Bilder; Walter Zahorodny; Sydney Pettygrove; Maureen S Durkin; Robert T Fitzgerald; Catherine Rice; Margaret Kurzius-Spencer; Jon Baio; Marshalyn Yeargin-Allsopp
Journal:  J Dev Behav Pediatr       Date:  2016-01       Impact factor: 2.225

6.  Pre- and postnatal effects of caffeine on brain biogenic amines, cyclic nucleotides and behavior in developing rats.

Authors:  J T Concannon; J M Braughler; M D Schechter
Journal:  J Pharmacol Exp Ther       Date:  1983-09       Impact factor: 4.030

7.  Caffeine use during pregnancy and child outcome: a 7-year prospective study.

Authors:  H M Barr; A P Streissguth
Journal:  Neurotoxicol Teratol       Date:  1991 Jul-Aug       Impact factor: 3.763

8.  Prenatal Caffeine Exposure and Child IQ at Age 5.5 Years: The EDEN Mother-Child Cohort.

Authors:  Cédric Galéra; Jonathan Y Bernard; Judith van der Waerden; Manuel-Pierre Bouvard; Sandrine Lioret; Anne Forhan; Maria De Agostini; Maria Melchior; Barbara Heude
Journal:  Biol Psychiatry       Date:  2015-09-03       Impact factor: 13.382

Review 9.  Overview of Cotinine Cutoff Values for Smoking Status Classification.

Authors:  Sungroul Kim
Journal:  Int J Environ Res Public Health       Date:  2016-12-14       Impact factor: 3.390

10.  Maternal smoking and autism spectrum disorder: meta-analysis with population smoking metrics as moderators.

Authors:  Yonwoo Jung; Angela M Lee; Sherry A McKee; Marina R Picciotto
Journal:  Sci Rep       Date:  2017-06-28       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.